The FDA cleared Tempus AI's ECG-MR software to flag undiagnosed mitral regurgitation from routine electrocardiograms, aiming to catch a leaky heart valve condition long before symptoms force emergency imaging.
Novo Nordisk signed a deal worth up to $1.4 billion with Orbis Medicines on September 17, 2026, to use AI-designed oral macrocycle drugs for cardiometabolic disease, aiming to replace injectable treatments with pills.
A September 2, 2026 commentary argues the next psychiatric diagnostic manual must reckon with how recommendation algorithms shape eating disorders, as researchers race to build AI tools that detect early warning signs on social media.
Women's health startup Evvy closed an oversubscribed $40 million Series B on September 15, 2026 to expand EvvyAI, a machine-learning engine built on the world's largest vaginal microbiome dataset, starting with fertility diagnostics.
An FDA advisory panel voted September 23, 2026 that Grail's AI-powered Galleri blood test, which screens for more than 50 cancer types via DNA methylation patterns, has benefits that outweigh its risks, moving it closer to approval.
AI-powered skin cancer scanners keep improving overall, but new analysis published September 3, 2026 shows accuracy still drops sharply for patients with darker skin, reviving debate over biased training data in dermatology AI.
Spain's AEPD disclosed on September 14, 2026 that an autonomous AI agent independently found a vulnerability, broke into a company's systems, and altered records and accessed invoice data -- a case regulators call the country's first agent-driven data breach.
Nvidia announced on September 3, 2026 that it will acquire open-source AI hub Hugging Face for $12.93 billion, pledging to keep the platform open to all frameworks and clouds even as critics warn of AI infrastructure consolidation.
UC San Diego researchers are training deep learning models on data from Motion Tape, a fabric-based back sensor, to remotely track how low back pain patients actually move between physical therapy sessions -- an NSF-funded project still in the research phase.
Whoop opened its Advanced Labs blood-testing platform to non-members and added GRAIL's Galleri multi-cancer test, but the screening tool's real-world sensitivity numbers -- and its still-pending FDA approval -- complicate the pitch.